Cargando…

Generic : The Unbranding of Modern Medicine /

Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Greene, Jeremy A., 1974- (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Baltimore : Johns Hopkins University Press, [2014]
Colección:Book collections on Project MUSE.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a22000004a 4500
001 musev2_72111
003 MdBmJHUP
005 20230905051427.0
006 m o d
007 cr||||||||nn|n
008 131209t20142014mdu o 00 0 eng d
010 |z  2013048851 
020 |a 9781421414942 
020 |z 9781421414935 
020 |z 9781421421643 
035 |a (OCoLC)1139372483 
040 |a MdBmJHUP  |c MdBmJHUP 
100 1 |a Greene, Jeremy A.,  |d 1974-  |e author. 
245 1 0 |a Generic :   |b The Unbranding of Modern Medicine /   |c Jeremy A. Greene. 
264 1 |a Baltimore :  |b Johns Hopkins University Press,  |c [2014] 
264 3 |a Baltimore, Md. :  |b Project MUSE,   |c 2020 
264 4 |c ©[2014] 
300 |a 1 online resource (376 pages):   |b illustrations ; 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a The same but not the same -- What's in a name? Ordering the world of cures ; The generic as critique of the brand -- No such thing as a generic drug? Drugs anonymous ; Origins of a self-effacing industry ; Generic specificity -- The sciences of similarity. Contests of equivalence ; The significance of differences -- Laws of substitution. Substitution as vice and virtue ; Universal exchange -- Paradoxes of generic consumption. Liberating the captive consumer ; Generic consumption in the clinic, pharmacy, and supermarket The generic alternative. Science and politics of the "me-too" drug ; Preferred drugs, public and private ; The global generic -- The crisis of similarity. 
520 |a Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. Questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Greene chronicles the social, political, and cultural history of generic drugs, narrating the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greene's history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care. 
546 |a Text in English. 
588 |a Description based on print version record. 
650 0 7 |a Indústria farmaceutica.  |2 lemac 
650 0 7 |a Medicaments generics.  |2 lemac 
650 7 |a Pharmazeutische Industrie  |2 gnd 
650 7 |a Generikum  |2 gnd 
650 7 |a Generic drugs.  |2 fast  |0 (OCoLC)fst00939969 
650 6 |a Medecine  |x Histoire  |y 21e siecle. 
650 6 |a Medecine  |x Histoire  |y 20e siecle. 
650 6 |a Medicaments generiques  |x Histoire. 
650 2 2 |a History, 21st Century 
650 2 2 |a History, 20th Century 
650 2 2 |a Drug Industry  |x history 
650 1 2 |a Drugs, Generic  |x history 
650 0 |a Generic drugs  |x History. 
651 7 |a USA  |2 gnd 
655 7 |a History.  |2 fast  |0 (OCoLC)fst01411628 
655 7 |a Electronic books.   |2 local 
710 2 |a Project Muse.  |e distributor 
830 0 |a Book collections on Project MUSE. 
856 4 0 |z Texto completo  |u https://projectmuse.uam.elogim.com/book/72111/ 
945 |a Project MUSE - Custom Collection